Crystal structure of a short-chain dehydrogenase from Burkholderia cenocepacia J2315 in complex with NADP+ and benzoic acid
Kafi K. J. Belfon,Olive Beyer,Jan Abendroth,David M. Dranow,Donald D. Lorimer,Ariel Abramov,Yazmine Latimore,Connor Hamilton,Aniah Dawkins,Isabella Hinojosa,Xavier Martinez,Sofia Mirabel,Miriam Duncan,Reagan Womack,Lillian Hicks,Zachary R. Turlington,Thomas E. Edwards,Andrew T. Torelli,Katherine A. Hicks,Jarrod B. French
DOI: https://doi.org/10.1107/s2053230x24011282
2024-12-01
Acta Crystallographica Section F Structural Biology Communications
Abstract:Burkholderia cenocepacia is an opportunistic human pathogen that can cause lethal infections in immunocompromised individuals, particularly those with cystic fibrosis. As such, there is a critical need to identify and characterize the structure and function of enzymes that participate in the metabolic pathways of this bacterium. Here, the high-resolution X-ray crystal structure of a short-chain dehydrogenase reductase (SDR) from B. cenocepacia J2315 (BcSDR) in complex with the coenzyme NADP+ and a benzoic acid ligand is presented. This protein has the conserved Rossmann fold of the SDR superfamily and the characteristic TGxxxGxG motif of the classical SDR subfamily. However, unlike classical SDRs, the active site of BcSDR has a leucine residue in place of the highly conserved and catalytically important tyrosine residue. Sequence analysis confirms that this leucine residue is conserved in this SDR across the Burkholderiales order. This suggests that BcSDR is more appropriately classified into the divergent SDR subfamily. In addition, this enzyme would necessarily employ a different enzyme mechanism to that proposed as a general mechanism for most SDRs.
biochemistry & molecular biology,biochemical research methods,biophysics,crystallography